| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033615 |
| Receipt No. | R000038319 |
| Official scientific title of the study | Prospective multicenter cohort study on the efficacy and safety of benralizumab in the treatment of severe asthma |
| Date of disclosure of the study information | 2018/08/03 |
| Last modified on | 2018/08/02 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Prospective multicenter cohort study on the efficacy and safety of benralizumab in the treatment of severe asthma | |
| Title of the study (Brief title) | Prospective multicenter cohort study on the efficacy and safety of benralizumab in the treatment of severe asthma | |
| Region |
|
|
| Condition | ||
| Condition | Bronchial Asthma | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of efficacy and safety of benralizumab in the treatment of severe asthma |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Spirometry |
| Key secondary outcomes | Astma Control Test(ACT), Asthma Control Questionnaire(ACQ), Asthma Quality of Life Questionnaire(AQLQ), FeNO, Objective opinion, Sputum eosinophil counts, Chest X-ray, Chest CT, Respiratory resistance test, Oral corticosteroid dose, Absence of unexpected visit and hospitalization due to asthma exacerbation, Clinical examination, Sinus CT, Safety |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Benralizumab is given subcutaneously | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients receiving oral corticosteroid daily
2. Patients with increasing of corticosteroid or needing corticosteroid temporalily at least twice a year due to asthma exacerbation 3. Patients with ACT<25 or ACQ>0 |
|||
| Key exclusion criteria | 1. Patients with intention to refuse to participate in this research.
2.Patients with a history of hypersensitivity to this drug and the ingredients of this drug. 3. Patients under 20 years old. 4. Patients who may be pregnant. 5. Patients with breastfeeding 6. Patients deemed ineligible by the attending physicians for various reasons. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Tachiwada |
| Organization | University of Occupational and Environmental Health, Japan |
| Division name | Department of Respiratory Medicine |
| Address | 1-1,Iseigaoka,Yahata-nishi-ku, Kitakyushu,Fukuoka,807-8555, Japan |
| TEL | 093-691-7453 |
| kokyu2@mbox.med.uoeh-u.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Tachiwada |
| Organization | University of Occupational and Environmental Health, Japan |
| Division name | Department of Respiratory Medicine |
| Address | 1-1,Iseigaoka,Yahata-nishi-ku, Kitakyushu,Fukuoka,807-8555, Japan |
| TEL | 093-691-7453 |
| Homepage URL | |
| kokyu2@mbox.med.uoeh-u.ac.jp | |
| Sponsor | |
| Institute | Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan
|
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038319 |